Perkins partners with Victor Chang Cardiac Research Institute for better heart outcomes
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cell Signalling, Community, Donation Handles, Media Releases, News & Events, Research, SarcomaThe Harry Perkins Institute of Medical Research has forged a new partnership with one of Australia’s leaders in heart research. The strategic partnership with the Victor Chang Cardiac Research Institute…
New heart health trial targets families with history of early heart attacks
By Richard Schoonraad | Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Cell Signalling, Community, Donation Handles, Heart, News & Events, Research, SarcomaA pioneering new study led by cardiologist Associate Professor Abdul Ihdayhid from the Harry Perkins Institute of Medical Research and Curtin University is offering new hope to families affected by…
Genetic tests to identify people at higher risk of heart failure
By Alicia Bienkowski | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Centre for Diabetes Research, Heart, Lab, Media Releases, News & Events, ResearchA groundbreaking study by researchers at Perth’s Harry Perkins Institute of Medical Research has produced a genetic test for heart failure, which will enable early intervention and more personalised treatment…
Biodesign program wins national award for excellence
By Richard Schoonraad | Molecular Endocrinology and Pharmacology, News & EventsA program that provides industry engagement opportunities and training in biomedical design thinking, while giving industry access to research talent has won a national award. iPREP Biodesign, administered by The…
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
Federal government supports new treatment to clear blocked arteries
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, ResearchA Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…
AI stethoscope to help detect early signs of heart disease
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, News & Events, TreatmentsNew AI stethoscope could revolutionise medicine and help detect the early signs of heart valve disease A digital stethoscope that will easily be able to detect early signs of heart…
Federally funded WA biomedical start-ups
By Richard Schoonraad | Antibiotic diagnostics, Bacteria, Kidneys, News & Events, Targeted Drug DeliveryCutting-edge biopolymer 3D printed heart valve technology and a rapid and accurate test to identify the most effective antibiotic treatment have commenced commercialisation in Western Australia to help millions globally.…